Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
AURIGA LABORATORIES, INC. (ARGA) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/15/2009 8-K Quarterly results
06/18/2008 8-K Form 8-K -- Current report
06/17/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
06/13/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Senior Secured Convertible Promissory Note",
"Royalty Participation Agreement",
"Senior Secured Convertible Promissory Note Purchase Agreement",
"Amendment No. 1 to Security Agreement",
"Amended and Restated Senior Secured Convertible Promissory Note"
05/20/2008 10-Q Quarterly Report for the period ended March 31, 2008
02/25/2008 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
02/19/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Senior Secured Promissory Note",
"Security Agreement",
"Auriga Laboratories, Inc. Common Stock Warrant",
"Senior Secured Note and Warrant Purchase Agreement",
"Royalty Participation Agreement"
02/14/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Convertible Promissory Note $240,000 Plus Interest Due & Payable, Document A-01152008",
"Convertible Promissory Note $1,800,000 Plus Interest Due & Payable, Document B-01152008",
"Secured & Collateralized Promissory Note $1,800,000 Plus Interest Due & Payable, Document C-01152008"
02/13/2008 424B3 Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/07/2008 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/30/2008 8-K/A Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Williams & Webster, P.S., addressed to the Securities and Exchange Commission in accordance with Item 304(a)(3) or Regulation S-B"
01/24/2008 8-K Termination of a Material Definitive Agreement, Changes in Registrant.s Certifying Accountant, Departure of Directors or Prin...
Docs: "Rescission Agreement",
"Letter from Williams & Webster, P.S., addressed to the Securities and Exchange Commission in accordance with Item 304(a)(3) or Regulation S-B",
"Frank R. Greico named CEO of Auriga Laboratories"
01/23/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/19/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Investment Agreement between Dutchess Private Equities Fund, Ltd. and Auriga Laboratories, Inc",
"Registration Rights Agreement between Dutchess Private Equities Fund, Ltd. and Auriga Laboratories, Inc",
"Commercial Lease",
"[email protected]"
12/18/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
12/13/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Stesso Pharmaceuticals, LLC Purchase Agreement"
12/03/2007 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "[email protected]"
11/16/2007 8-K Changes in Control of Registrant
11/09/2007 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Transcript of Auriga Laboratories, Inc. conference call held November 8, 2007"
11/08/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Auriga Laboratories Reports Third Quarter 2007 Financial Results"
11/05/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Manufacturing and Supply Agreement with Mikart, Inc.",
"Auriga Laboratories obtains rights to market and sell an FDA-approved product indicated for the treatment of mild to moderately severe pain."
11/02/2007 8-K Changes in Control of Registrant
10/24/2007 424B3 Form 424B3 -- Prospectus [Rule 424(b)(3)]
10/22/2007 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Auriga Laboratories To Announce Third Quarter Financial Results on Thursday, November 8th Company To Hold Conference Call at 4:30 p.m. Eastern Time That Day",
"Auriga Laboratories Continues Sale Force Expansion to Position for 2008"
10/18/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Licensing and Distribution Agreement by and between Auriga Laboratories, Inc. and Laboratoires Carilene S.A.S (unredacted version)"
10/05/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities
10/02/2007 8-K Termination of a Material Definitive Agreement
10/02/2007 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Secu...
Docs: "Form of Stock Purchase Agreement",
"Form of Warrant",
"Form of Conversion Notice"
09/05/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Auriga Laboratories’ Executives Terminate 10b5-1 Trading Plans"
08/30/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Auriga Laboratories’ Chief Executive Officer Terminates 10b5-1 Trading Plans"
08/28/2007 8-K Appointed CFO
Docs: "Executive Employment Agreement entered into between Auriga Laboratories, Inc. and Frank Greico",
"Indemnification Agreement entered into between Auriga Laboratories, Inc. and Frank Greico",
"Form of Auriga Laboratories, Inc. Nonstatutory Stock Option for Frank Greico",
"Amended Executive Employment Agreement entered into between Auriga Laboratories, Inc. and Chuck Bearchell",
"Amended Auriga Laboratories, Inc. Nonstatutory Stock Option granted to Chuck Bearchell",
"Auriga Laboratories Appoints Frank R. Greico as Chief Financial Officer"
08/10/2007 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Investor Presentation of Auriga Laboratories, Inc",
"Investor Fact Sheet, Third Quarter 2007"
08/10/2007 424B3 Form 424B3 -- Prospectus [Rule 424(b)(3)]
08/07/2007 8-K Quarterly results
Docs: "Auriga Laboratories Reports Record Second Quarter 2007 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy